News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aduro Biotech CDMRP Grant for Prostate Cancer Vaccine Development


9/6/2012 10:21:32 AM

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc. announces the award of a Congressionally Directed Medical Research Programs (CDMRP) grant from the Department of Defense. The grant of $867,846 will be used to complete the preclinical development of a novel therapeutic cancer vaccine for prostate cancer.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES